-transparent.png){kind=logo}
The half life of released plasma histamine (HA) is short but N-methylhistamine (N-MHA) which is a metabolite of HA has a longer life. Measuring both HA and N-MHA, it is possible to know the release of HA in the plasma. The purpose of this study was to ascertain the release of HA by pipecuronium (PPB) by measuring both HA and N-MHA in the plasma. Ten patients received 0.04 mg.kg-1 and other 10 patients received 0.08 mg.kg-1 of intravenous PPB. Plasma levels of HA and N-MHA were measured 1 minute before and 1, 3, 5 and 10 minutes after the administration of PPB. Release of plasma HA and N-MHA was not observed following administration of PPB. We concluded that PPB does not cause the release of histamine because there is no increase of the metabolite, N-MHA, of HA, and PPB can be used safely for patients with allergy.
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
February 1959,
The Journal of clinical endocrinology and metabolism,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
February 1958,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
October 1947,
Science (New York, N.Y.),
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
February 1989,
Masui. The Japanese journal of anesthesiology,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
September 1988,
The Journal of pharmacy and pharmacology,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
July 1976,
British journal of pharmacology,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
March 1998,
Resuscitation,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
August 1983,
The American journal of medicine,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
August 1957,
Archives internationales de pharmacodynamie et de therapie,
E Ueda, and
J Takeda, and
J Takahashi, and
K Fukushima
May 1984,
Toxicology letters,
